Patents/Assignees

Astrazeneca AB

80 patents in portfolio

US12617795utility2026
Substituted 6,7-dihydro-5h-pyrrolo[3,4-d]pyrimidines, 5,7-dihydrofuro[3,4-d]pyrimidines, and Pyrido[2,3-d]pyrimidines as KCC2 Modulators
0 cites
4.5 ★
US12620146utility2026
Graph Construction and Visualization of Multiplex Immunofluorescence Images
0 cites
4.0 ★
USD1125537design2026
Medical Injector
0 cites
US12613173utility2026
Apparatus and Method for Evaluating Physical Strength or Robustness of Solid Pharmaceutical Dosage Forms Based on an Impact Strike Test
0 cites
US12606555utility2026
Chemical Compounds
0 cites
US12582716utility2026
Stable, Aqueous Formulations of Antibodies That Bind IL5 Receptor
0 cites
US12584120utility2026
PCSK9 Inhibitors and Methods of Use Thereof
0 cites
US12569489utility2026
1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4h-pyrrolo[3,2-d]pyrimidin-4-ones as Inhibitors of Myeloperoxidase
0 cites
US12552807utility2026
PCSK9 Inhibitors and Methods of Use Thereof
0 cites
US12539299utility2026
Oral Formulation of a Therapeutic Compound
0 cites
US12509702utility2025
Inducible Modification of a Cell Genome
0 cites
US12502355utility2025
Solid Pharmaceutical Formulations of 6-(2-chloro-6-methylpyridin-4-yl)-5-(4-fluorophenyl)-1,2,4-triazin-3-amine
0 cites
US12502398utility2025
Combination Therapy for Treating Cancer
0 cites
US12473272utility2025
JAK1 Selective Inhibitors
0 cites
US12472194utility2025
Methods of Treating Heart Failure with Preserved Ejection Fraction Employing Dapagliflozin and Compositions Comprising the Same
0 cites
US12465608utility2025
Osimertinib for Use in the Treatment of Non-small Cell Lung Cancer
0 cites
US12453729utility2025
Pharmaceutical Formulations
0 cites
US12448385utility2025
Substituted Indazoles as IRAK4 Inhibitors
0 cites
US12441744utility2025
2,6,9-trisubstituted Purines
0 cites
US12435097utility2025
Arginase Inhibitors and Methods of Use Thereof
0 cites

Page 1 of 4Next →